Advertisement
Screener

Eagle Pharmaceuticals, Inc. Net Income

Eagle Pharmaceuticals, Inc. Net Income

Eagle Pharmaceuticals, Inc. reported Net Income of $5.16 million for the 3-month period ending 2023-06-30, per its 10-Q/A filed 2023-08-09.

Discontinued › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2023-08-09

  • Eagle Pharmaceuticals, Inc. net income (loss) attributable to parent for the quarter ending 2023-06-30 was $5.16M.
  • Eagle Pharmaceuticals, Inc. net income (loss) attributable to parent for the quarter ending 2023-03-31 was $5.75M, a 86.95% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. net income (loss) attributable to parent for the quarter ending 2022-12-31 was $8.16M.
  • Eagle Pharmaceuticals, Inc. net income (loss) attributable to parent for the quarter ending 2022-09-30 was -$7.13M.
  • Eagle Pharmaceuticals, Inc. net income (loss) attributable to parent for fiscal 2022 was $35.64M.
  • Eagle Pharmaceuticals, Inc. net income (loss) attributable to parent for fiscal 2021 was -$8.63M, a 171.96% decline from fiscal 2020.
  • Eagle Pharmaceuticals, Inc. net income (loss) attributable to parent for fiscal 2020 was $11.99M, a 16.24% decline from fiscal 2019.
  • Eagle Pharmaceuticals, Inc. net income (loss) attributable to parent for fiscal 2019 was $14.31M, a 55.14% decline from fiscal 2018.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 3 month as first filedNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 12 month
2023-06-30$5.16M
10-Q/A · filed 2023-08-09
$10.91M
10-Q/A · filed 2023-08-09
$19.08M
derived: sum of 3 quarters · filed 2023-08-09
$11.95M
derived: sum of 4 quarters · filed 2023-08-09
2023-03-31$5.75M
10-Q · filed 2023-05-09
$13.91M
derived: sum of 2 quarters · filed 2023-05-09
$6.78M
derived: sum of 3 quarters · filed 2023-05-09
-$2.67M
derived: sum of 4 quarters · filed 2023-08-09
2022-12-31$8.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$1.03M
derived: sum of 2 quarters · filed 2023-03-23
-$8.42M
derived: sum of 3 quarters · filed 2023-08-09
$35.64M
10-K · filed 2023-03-23
2022-09-30-$7.13M
10-Q · filed 2022-11-09
-$16.58M
derived: sum of 2 quarters · filed 2023-08-09
$27.48M
10-Q · filed 2022-11-09
$21.28M
derived: sum of 4 quarters · filed 2023-08-09
2022-06-30-$9.45M
10-Q/A · filed 2023-08-09
$34.61M
10-Q/A · filed 2023-08-09
$28.41M
derived: sum of 3 quarters · filed 2023-08-09
$22.79M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$44.06M
10-Q · filed 2023-05-09
$37.86M
derived: sum of 2 quarters · filed 2023-05-09
$32.24M
derived: sum of 3 quarters · filed 2023-05-09
$35.85M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31-$6.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
-$11.82M
derived: sum of 2 quarters · filed 2023-03-23
-$8.21M
derived: sum of 3 quarters · filed 2023-03-23
-$8.63M
10-K · filed 2023-03-23
2021-09-30-$5.62M
10-Q · filed 2022-11-09
-$2.01M
derived: sum of 2 quarters · filed 2022-11-09
-$2.43M
10-Q · filed 2022-11-09
$5.63M
derived: sum of 4 quarters · filed 2023-03-23
2021-06-30$3.61M
10-Q · filed 2022-08-09
$3.19M
10-Q · filed 2022-08-09
$11.25M
derived: sum of 3 quarters · filed 2023-03-23
$18.31M
derived: sum of 4 quarters · filed 2023-03-23
2021-03-31-$421.00K
10-Q · filed 2022-05-09
$7.64M
derived: sum of 2 quarters · filed 2023-03-23
$14.70M
derived: sum of 3 quarters · filed 2023-03-23
$14.44M
derived: sum of 4 quarters · filed 2023-03-23
2020-12-31$8.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$15.12M
derived: sum of 2 quarters · filed 2023-03-23
$14.86M
derived: sum of 3 quarters · filed 2023-03-23
$11.99M
10-K · filed 2023-03-23
2020-09-30$7.06M
10-Q · filed 2021-11-09
$6.80M
derived: sum of 2 quarters · filed 2021-11-09
$3.93M
10-Q · filed 2021-11-09
$4.94M
derived: sum of 4 quarters · filed 2022-03-08
2020-06-30-$256.00K
10-Q · filed 2021-08-09
-$3.13M
10-Q · filed 2021-08-09
-$2.12M
derived: sum of 3 quarters · filed 2022-03-08
-$4.51M
derived: sum of 4 quarters · filed 2022-03-08
2020-03-31-$2.87M
10-Q · filed 2021-05-10
-$1.87M
derived: sum of 2 quarters · filed 2022-03-08
-$4.26M
derived: sum of 3 quarters · filed 2022-03-08
$2.47M
derived: sum of 4 quarters · filed 2022-03-08
2019-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
-$1.39M
derived: sum of 2 quarters · filed 2022-03-08
$5.34M
derived: sum of 3 quarters · filed 2022-03-08
$14.31M
10-K · filed 2022-03-08
2019-09-30-$2.39M
10-Q · filed 2020-11-02
$4.33M
derived: sum of 2 quarters · filed 2020-11-02
$13.31M
10-Q · filed 2020-11-02
$25.90M
derived: sum of 4 quarters · filed 2021-03-05
2019-06-30$6.72M
10-Q · filed 2020-08-10
$15.70M
10-Q · filed 2020-08-10
$28.29M
derived: sum of 3 quarters · filed 2021-03-05
$42.33M
derived: sum of 4 quarters · filed 2021-03-05
2019-03-31$8.97M
10-Q · filed 2020-05-11
$21.56M
derived: sum of 2 quarters · filed 2021-03-05
$35.60M
derived: sum of 3 quarters · filed 2021-03-05
$38.26M
derived: sum of 4 quarters · filed 2021-03-05
2018-12-31$12.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05
$26.63M
derived: sum of 2 quarters · filed 2021-03-05
$29.29M
derived: sum of 3 quarters · filed 2021-03-05
$31.90M
10-K · filed 2021-03-05
2018-09-30$14.04M
10-Q · filed 2019-11-12
$16.70M
derived: sum of 2 quarters · filed 2019-11-12
$19.31M
10-Q · filed 2019-11-12
$28.40M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$2.66M
10-Q · filed 2019-08-08
$5.28M
10-Q · filed 2019-08-08
$14.36M
derived: sum of 3 quarters · filed 2020-03-02
$29.79M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$2.62M
10-Q · filed 2019-05-07
$11.70M
derived: sum of 2 quarters · filed 2020-03-02
$27.13M
derived: sum of 3 quarters · filed 2020-03-02
$31.64M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$9.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$24.52M
derived: sum of 2 quarters · filed 2020-03-02
$29.02M
derived: sum of 3 quarters · filed 2020-03-02
$51.94M
10-K · filed 2020-03-02
2017-09-30$15.43M
10-Q · filed 2018-11-01
$19.93M
derived: sum of 2 quarters · filed 2018-11-01
$42.86M
10-Q · filed 2018-11-01
$100.16M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$4.50M
10-Q · filed 2018-08-07
$27.43M
10-Q · filed 2018-08-07
$84.73M
derived: sum of 3 quarters · filed 2019-02-28
$96.68M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$22.92M
10-Q · filed 2018-05-10
$80.22M
derived: sum of 2 quarters · filed 2019-02-28
$92.18M
derived: sum of 3 quarters · filed 2019-02-28
$105.28M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$57.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$69.25M
derived: sum of 2 quarters · filed 2019-02-28
$82.35M
derived: sum of 3 quarters · filed 2019-02-28
$81.45M
10-K · filed 2019-02-28
2016-09-30$11.95M
10-Q · filed 2017-11-08
$25.05M
derived: sum of 2 quarters · filed 2017-11-08
$24.15M
10-Q · filed 2017-11-08
$25.37M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30$13.10M
10-Q · filed 2017-08-09
$12.20M
10-Q · filed 2017-08-09
$13.42M
derived: sum of 3 quarters · filed 2018-02-26
$3.25M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31-$896.00K
10-Q · filed 2017-05-08
$323.00K
derived: sum of 2 quarters · filed 2018-02-26
-$9.84M
derived: sum of 3 quarters · filed 2018-02-26
-$18.02M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31$1.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
-$8.95M
derived: sum of 2 quarters · filed 2018-02-26
-$17.13M
derived: sum of 3 quarters · filed 2018-02-26
$2.57M
10-K · filed 2018-02-26
2015-09-30-$10.17M
10-Q · filed 2016-11-09
-$18.34M
derived: sum of 2 quarters · filed 2016-11-09
$1.35M
10-Q · filed 2016-11-09
-$4.15M
derived: sum of 4 quarters · filed 2017-03-15
2015-06-30-$8.18M
10-Q · filed 2016-08-09
$11.52M
10-Q · filed 2016-08-09
$6.01M
derived: sum of 3 quarters · filed 2017-03-15
-$3.09M
derived: sum of 4 quarters · filed 2017-03-15
2015-03-31$19.70M
10-Q · filed 2016-05-10
$14.19M
derived: sum of 2 quarters · filed 2017-03-15
$5.09M
derived: sum of 3 quarters · filed 2017-03-15
$2.15M
derived: sum of 4 quarters · filed 2017-03-15
2014-12-31-$5.51M
10-K · filed 2017-03-15
-$14.61M
derived: sum of 2 quarters · filed 2017-03-15
-$17.54M
derived: sum of 3 quarters · filed 2017-03-15
-$20.23M
derived: sum of 4 quarters · filed 2017-03-15
2014-09-30-$9.10M
10-Q · filed 2015-11-12
-$12.04M
derived: sum of 2 quarters · filed 2015-11-12
-$14.72M
10-Q · filed 2015-11-12
-$17.98M
10-K · filed 2017-03-15
2014-06-30-$2.93M
10-Q · filed 2015-08-11
-$2.93M
10-Q · filed 2014-08-11
-$5.62M
10-Q · filed 2015-08-11
-$8.87M
10-Q · filed 2014-08-11
-$8.39M
derived: sum of 4 quarters · filed 2017-03-15
2014-03-31-$2.68M
10-Q · filed 2015-05-15
-$2.68M
10-Q · filed 2014-05-15
-$5.94M
10-Q · filed 2014-05-15
-$5.46M
derived: sum of 3 quarters · filed 2017-03-15
-$4.70M
derived: sum of 4 quarters · filed 2017-03-15
2013-12-31-$3.25M
10-K · filed 2017-03-15
-$2.77M
derived: sum of 2 quarters · filed 2017-03-15
-$2.02M
derived: sum of 3 quarters · filed 2017-03-15
-$6.82M
derived: sum of 4 quarters · filed 2017-03-15
2013-09-30$483.80K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$1.24M
derived: sum of 2 quarters · filed 2016-02-29
-$3.57M
derived: sum of 3 quarters · filed 2016-02-29
-$6.05M
10-K · filed 2016-02-29
2013-06-30$754.58K
10-Q · filed 2014-08-11
-$4.05M
derived: sum of 2 quarters · filed 2014-08-11
-$6.53M
10-Q · filed 2014-08-11
2013-03-31-$4.80M
10-Q · filed 2014-05-15
-$7.29M
10-Q · filed 2014-05-15
2012-09-30-$19.38M
10-K · filed 2014-12-22